维门通过ARVCF调节替代多化和mTOR信号,促进B细胞淋巴瘤的进展
Lujing Shao1, Qianke Xing1, Yao Xiong2
1Department of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.
Human mutation
|October 8, 2025
概括
在B细胞淋巴瘤中,维门的损失通过改变mRNA处理和通过ARVCF-RRAGA通路激活mTOR信号来促进瘤生长. 这一发现为淋巴瘤提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 维丁 (VIM) 与B细胞淋巴瘤的预后不佳有关.
- 替代多氨基化 (APA) 失调在癌症中很常见.
- 在B细胞淋巴瘤中VIM-APA的相互作用尚不清楚.
研究的目的:
- 调查维门丁 (VIM) 在调节B细胞淋巴瘤的替代多化 (APA) 中的作用.
- 阐明连接VIM,APA和瘤信号通路的分子机制,特别是mTOR.
- 为了确定B细胞淋巴瘤的潜在治疗点.
主要方法:
- 在VIM-knockout B细胞淋巴瘤模型中进行RNA测序和APA分析 (DaPars).
- 蛋白质基因分析,以确定蛋白质的变化.
- 功能性测试 (CCK-8,EdU,Western blot) 和过度表达研究,以探索调节轴.
主要成果:
- VIM删除引发了广泛的转录组变化和4089个APA缩短事件,影响了像mTORC1.1.这样的生存途径.
- RRAGA是一种mTOR激活剂,显示3'UTR缩短和ARVCF下调.
- 发现ARVCF可以维持RRAGA 3'UTR的长度,并抑制mTOR-EIF4G1信号传输,从而抑制淋巴瘤的扩散.
结论:
- 在B细胞淋巴瘤中发现了一种新的VIM-ARVCF-RRAGA-mTOR信号轴.
- 通过ARVCF降低调节,VIM损失通过驱动APA缩短和mTOR激活来促进淋巴瘤的进展.
- 这些发现提供了机制性的见解,并建议了淋巴瘤的潜在治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
B Cell Activation and Differentiation
16.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.0K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


